152 related articles for article (PubMed ID: 29950003)
21. Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools.
Garcia-Prieto CA; Martínez-Jiménez F; Valencia A; Porta-Pardo E
Bioinformatics; 2022 Jun; 38(12):3181-3191. PubMed ID: 35512388
[TBL] [Abstract][Full Text] [Related]
22. Evaluating somatic tumor mutation detection without matched normal samples.
Teer JK; Zhang Y; Chen L; Welsh EA; Cress WD; Eschrich SA; Berglund AE
Hum Genomics; 2017 Sep; 11(1):22. PubMed ID: 28870239
[TBL] [Abstract][Full Text] [Related]
23. A new correlation clustering method for cancer mutation analysis.
Hou JP; Emad A; Puleo GJ; Ma J; Milenkovic O
Bioinformatics; 2016 Dec; 32(24):3717-3728. PubMed ID: 27540270
[TBL] [Abstract][Full Text] [Related]
24. Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.
Tokheim C; Bhattacharya R; Niknafs N; Gygax DM; Kim R; Ryan M; Masica DL; Karchin R
Cancer Res; 2016 Jul; 76(13):3719-31. PubMed ID: 27197156
[TBL] [Abstract][Full Text] [Related]
25. De novo discovery of mutated driver pathways in cancer.
Vandin F; Upfal E; Raphael BJ
Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
[TBL] [Abstract][Full Text] [Related]
26. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
Zhang J; Zhang S; Wang Y; Zhang XS
BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
[TBL] [Abstract][Full Text] [Related]
27. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
28. LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer.
Melloni GE; de Pretis S; Riva L; Pelizzola M; Céol A; Costanza J; Müller H; Zammataro L
BMC Bioinformatics; 2016 Feb; 17():80. PubMed ID: 26860319
[TBL] [Abstract][Full Text] [Related]
29. LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network.
Wei PJ; Zhang D; Xia J; Zheng CH
BMC Bioinformatics; 2016 Dec; 17(Suppl 17):467. PubMed ID: 28155630
[TBL] [Abstract][Full Text] [Related]
30. Multiscale mutation clustering algorithm identifies pan-cancer mutational clusters associated with pathway-level changes in gene expression.
Poole W; Leinonen K; Shmulevich I; Knijnenburg TA; Bernard B
PLoS Comput Biol; 2017 Feb; 13(2):e1005347. PubMed ID: 28170390
[TBL] [Abstract][Full Text] [Related]
31. 3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets.
Gao J; Chang MT; Johnsen HC; Gao SP; Sylvester BE; Sumer SO; Zhang H; Solit DB; Taylor BS; Schultz N; Sander C
Genome Med; 2017 Jan; 9(1):4. PubMed ID: 28115009
[TBL] [Abstract][Full Text] [Related]
32. A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations.
Ryslik GA; Cheng Y; Cheung KH; Modis Y; Zhao H
BMC Bioinformatics; 2014 Mar; 15():86. PubMed ID: 24669769
[TBL] [Abstract][Full Text] [Related]
33. e-Driver: a novel method to identify protein regions driving cancer.
Porta-Pardo E; Godzik A
Bioinformatics; 2014 Nov; 30(21):3109-14. PubMed ID: 25064568
[TBL] [Abstract][Full Text] [Related]
34. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
35. PersonaDrive: a method for the identification and prioritization of personalized cancer drivers.
Erten C; Houdjedj A; Kazan H; Taleb Bahmed AA
Bioinformatics; 2022 Jun; 38(13):3407-3414. PubMed ID: 35579340
[TBL] [Abstract][Full Text] [Related]
36. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
37. iCAGES: integrated CAncer GEnome Score for comprehensively prioritizing driver genes in personal cancer genomes.
Dong C; Guo Y; Yang H; He Z; Liu X; Wang K
Genome Med; 2016 Dec; 8(1):135. PubMed ID: 28007024
[TBL] [Abstract][Full Text] [Related]
38. Identification of druggable cancer driver genes amplified across TCGA datasets.
Chen Y; McGee J; Chen X; Doman TN; Gong X; Zhang Y; Hamm N; Ma X; Higgs RE; Bhagwat SV; Buchanan S; Peng SB; Staschke KA; Yadav V; Yue Y; Kouros-Mehr H
PLoS One; 2014; 9(5):e98293. PubMed ID: 24874471
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive identification of mutational cancer driver genes across 12 tumor types.
Tamborero D; Gonzalez-Perez A; Perez-Llamas C; Deu-Pons J; Kandoth C; Reimand J; Lawrence MS; Getz G; Bader GD; Ding L; Lopez-Bigas N
Sci Rep; 2013 Oct; 3():2650. PubMed ID: 24084849
[TBL] [Abstract][Full Text] [Related]
40. DMCM: a Data-adaptive Mutation Clustering Method to identify cancer-related mutation clusters.
Lu X; Qian X; Li X; Miao Q; Peng S
Bioinformatics; 2019 Feb; 35(3):389-397. PubMed ID: 30010784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
